The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer

Overview of attention for article published in Frontiers in oncology, September 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 4 X users

reddit: 1 Redditor

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Reddit Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 10,688 followers.

The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4013ALK ... https://t.co/2xrGJPNrhR

14 Oct 2021

Reply Repost Favourite

The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4-ALK Rearranged Non-small Cell Lung Cancer. #lymphoma #lymsm https://t.co/kUKZzqmCYD

15 Oct 2019

Reply Repost Favourite

RT @FrontOncology: New research: The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced E…

28 Sep 2019

Reply Repost Favourite

New research: The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer: Patients' clinical factors and genetics factors such as anaplastic lymphoma… https://t.co

27 Sep 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.